uniQure Announces Presentations at Upcoming March Conferences
March 01 2017 - 7:00AM
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 01, 2017
(GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene
therapy company advancing transformative therapies for patients
with severe medical needs, today announced presentations at the
following conferences taking place in March:
37th Annual
Cowen & Co. Healthcare Conference, at the Boston Marriott
Copley Place, in Boston Massachusetts.
-
Matthew Kapusta, chief executive officer, will
present on Wednesday, March 8th at
10.00 a.m. EST. The live webcast can be accessed through the link
displayed in the Investor section of the uniQure website
at: http://uniqure.com/investors-newsroom/events-presentations.php.
The webcast replay will be available for at least two weeks
following the live event.
Oppenheimer
27th Annual Healthcare Conference, at the Westin New York Grand
Central, in New York City.
-
Matthew Kapusta, chief executive officer, will
participate in a Fireside Chat with analyst Hartaj Singh on Tuesday
March 21st at 3.55
p.m. EST. The live webcast can be accessed through the link
displayed in the Investor section of the uniQure website
at: http://uniqure.com/investors-newsroom/events-presentations.php.
The webcast replay will be available for at least two weeks
following the live event.
11th Annual
Symposium of the Coalition for Hemophilia B, at the Sawgrass
Marriott Golf Resort in Ponte Vedra, Florida.
About
uniQure
uniQure is delivering on the promise of gene therapy - single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with hemophilia, Huntington's disease and cardiovascular
diseases. www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: uniQure N.V. via Globenewswire
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024